CVS HEALTH

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

322

Firms Hired

Active Period

2013–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	11	5
2025	—	21	5
2024	—	16	4
2023	—	23	7
2022	—	29	7
2021	—	30	8
2020	—	36	10
2019	—	61	13
2018	—	30	9
2017	—	23	6
2016	—	17	4
2015	—	12	3
2014	—	8	1
2013	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
KOUNTOUPES DENHAM CARR & REID, LLC	—	47
KLEIN/JOHNSON GROUP	—	35
ALSTON & BIRD LLP	—	33
KATE MOSS	—	35
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ	—	35
MILLER & CHEVALIER Chartered	—	35
KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)	—	33
AKIN GUMP STRAUSS HAUER FELD	—	19
CONTINENTAL STRATEGY, LLC	—	8
HARBINGER STRATEGIES, LLC	—	6
VANTAGEKNIGHT LLC	—	7
MCDERMOTT+ LLC	—	6
ML STRATEGIES, LLC	—	5
BARNES & THORNBURG, LLP	—	5
BAKER & MCKENZIE LLP	—	13

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	271
HOUSE OF REPRESENTATIVES	264
Centers For Medicare and Medicaid Services (CMS)	32
Food & Drug Administration (FDA)	32
Health & Human Services, Dept of (HHS)	29
Executive Office of the President (EOP)	18
Treasury, Dept of	11
White House Office	10
Vice President of the U.S.	6
Federal Trade Commission (FTC)	5
Internal Revenue Service (IRS)	3
Office of Management & Budget (OMB)	3
Office of the Vice President of the United States	3

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	197
Pharmacy	Pharmacy	146
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	117
Labor Issues/Antitrust/Workplace	Labor Issues/Antitrust/Workplace	69
Medicare/Medicaid	Medicare/Medicaid	56
Postal	Postal	32
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	25
Insurance	Insurance	10
Veterans	Veterans	9
Budget/Appropriations	Budget/Appropriations	3
Agriculture	Agriculture	3
Copyright/Patent/Trademark	Copyright/Patent/Trademark	1
Accounting	Accounting	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3164119th Congress

Ensuring Community Access to Pharmacist Services Act

2025 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 3164

S. 2426119th Congress

Equitable Community Access to Pharmacist Services Act

2025 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.

Client expense: — · Firm income: $60,000

Matched citations: S.2426

H.R. 3164119th Congress

Ensuring Community Access to Pharmacist Services Act

2025 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 3164

S. 2426119th Congress

Equitable Community Access to Pharmacist Services Act

2025 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.

Client expense: — · Firm income: $60,000

Matched citations: S.2426

Show 21 more cited filings

H.R. 1770118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R.1770 and S.2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability. Issues related to pharmaceutical supply chains.

Client expense: — · Firm income: $60,000

Matched citations: H.R.1770

H.R. 1770118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R.1770

S. 2477118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act.

Client expense: — · Firm income: $60,000

Matched citations: S.2477

S. 2477118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R.1770 and S.2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability. Issues related to pharmaceutical supply chains.

Client expense: — · Firm income: $60,000

Matched citations: S.2477

H.R. 1770118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R.1770 and S.2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability. Issues related to pharmaceutical supply chains.

Client expense: — · Firm income: $60,000

Matched citations: H.R.1770

H.R. 1770118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R.1770

S. 2477118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act.

Client expense: — · Firm income: $60,000

Matched citations: S.2477

S. 2477118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R.1770 and S.2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability. Issues related to pharmaceutical supply chains.

Client expense: — · Firm income: $60,000

Matched citations: S.2477

H.R. 1770118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R. 1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1770

H.R. 1770118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1770

S. 2477118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability.

Client expense: — · Firm income: $60,000

Matched citations: S. 2477

S. 2477118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · second_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R. 1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 2477

H.R. 1770118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act. Issues related to prescription drug access and affordability.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1770

H.R. 1770118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R. 1770

S. 2477118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 2477

S. 2477118th Congress

Equitable Community Access to Pharmacist Services Act

2024 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act. Issues related to prescription drug access and affordability.

Client expense: — · Firm income: $60,000

Matched citations: S. 2477

H.R. 1770118th Congress

Equitable Community Access to Pharmacist Services Act

2023 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act.

Client expense: — · Firm income: $80,000

Matched citations: H.R. 1770

H.R. 1770118th Congress

Equitable Community Access to Pharmacist Services Act

2023 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act. Issues related to prescription drug access and affordability.

Client expense: — · Firm income: $80,000

Matched citations: H.R. 1770

S. 2477118th Congress

Equitable Community Access to Pharmacist Services Act

2023 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act.

Client expense: — · Firm income: $80,000

Matched citations: S. 2477

S. 2477118th Congress

Equitable Community Access to Pharmacist Services Act

2023 · fourth_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act. Issues related to prescription drug access and affordability.

Client expense: — · Firm income: $80,000

Matched citations: S. 2477

H.R. 1770118th Congress

Equitable Community Access to Pharmacist Services Act

2023 · third_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act.

Client expense: — · Firm income: $80,000

Matched citations: H.R. 1770

Source: Senate LDA

CVS HEALTH — Lobbying Disclosure | Poliscope